| Literature DB >> 28279976 |
Suk-Jin Yang1,2, Young Soo Park1,3, Jung Hee Cho4, Byul Moon1,3, Hyun-Jung An4, Ju Yeon Lee5, Zhi Xie6, Yuli Wang6, David Pocalyko6, Dong Chul Lee1, Hyun Ahm Sohn1, Minho Kang4, Jin Young Kim5, Eunhee Kim2, Kyung Chan Park7,4, Jung-Ae Kim7,4, Young Il Yeom8,3.
Abstract
Oxygen deprivation induces a range of cellular adaptive responses that enable to drive cancer progression. Here, we report that lysine-specific demethylase 1 (LSD1) upregulates hypoxia responses by demethylating RACK1 protein, a component of hypoxia-inducible factor (HIF) ubiquitination machinery, and consequently suppressing the oxygen-independent degradation of HIF-1α. This ability of LSD1 is attenuated during prolonged hypoxia, with a decrease in the cellular level of flavin adenine dinucleotide (FAD), a metabolic cofactor of LSD1, causing HIF-1α downregulation in later stages of hypoxia. Exogenously provided FAD restores HIF-1α stability, indicating a rate-limiting role for FAD in LSD1-mediated HIF-1α regulation. Transcriptomic analyses of patient tissues show that the HIF-1 signature is highly correlated with the expression of LSD1 target genes as well as the enzymes of FAD biosynthetic pathway in triple-negative breast cancers, reflecting the significance of FAD-dependent LSD1 activity in cancer progression. Together, our findings provide a new insight into HIF-mediated hypoxia response regulation by coupling the FAD dependence of LSD1 activity to the regulation of HIF-1α stability.Entities:
Keywords: FAD biosynthesis; HIF‐1; LSD1; cancer; hypoxia
Mesh:
Substances:
Year: 2017 PMID: 28279976 PMCID: PMC5391145 DOI: 10.15252/embj.201694408
Source DB: PubMed Journal: EMBO J ISSN: 0261-4189 Impact factor: 11.598